Jan 18, 2017
Price: Cost savings initiatives shouldn't dictate treatments
I've seen in certain instances, what's coming out of CMMI is a desire to require certain kinds of treatment for certain disease entities that may or may not be in the best interest of the patient."— Tom Price, testifying on the Center for Medicare and Medicaid Innovation
For more on Price's opposition to the center's initiatives, read Steven Brill's piece on Price and cost savings.